Posted on 11th November 2019

E2DG form strategic collaboration with Fusion Antibodies to provide end-to-end service for oncology drug discovery companies.

To get more information follow this link.

        

 

April 24-29, 2020

AACR Annual Meeting 2020, San Diego, California.

Don’t miss the opportunity to meet our team to discuss your project in oncology during the AACR in San Diego!

To get more information on this conference follow this link.

 

December 10-11, 2019

BioFit 2019, Marseille, France.

Don’t miss the opportunity to meet our team to discuss your project in oncology during BioFIt Conference!

To get more information on this conference follow this link.

 

November 11–13, 2019

BioEurope 2019, Hamburg, Germany.

Please contact us to organize a meeting with E2DG team during BioEurope 2019. To get more information on this conference follow this link.

 

October 15-17, 2019

1st COST Action CA17140 Conference. Riga, Latvia.

The Conference programs includes the following sessions: 

– design, sythesis, scale up and GMP aspects of nanodrugs

– physico-chemical characterization of nanodrugs

– preclinical studies of nanodrugs

– clinical trials and regulatory aspects of nanomedicines.

You are all kindly invited to submit an abstract to the conference. 

Don’t miss the opportunity to meet our CSO, Dr Riveiro Maria Eugenia will be participating to the COST Management Committee meeting and the Conference. To get more information on this conference follow this link.

 

September 10-12, 2019

NORDIC LIFE SCIENCE DAYS 2019, Malmö, Sweden.

Don’t miss the opportunity to meet our team to discuss your project in oncology during the NLS Days!

To get more information on this conference follow this link.

 

June 17 – 21, 2019

We are proud to announce the first week dedicated to gender equality in science, June 17 – 21 at the Institut Pasteur. Our CSO, Dr Riveiro Maria Eugenia will be participating together with other inspiring women representatives of the science, technology and innovation fields.

 

 

March 25th, 2019

RESI CONFERENCE. Early stage investors and strategic partners matched with fundraising CEOS and scientist-entrepreneurs, Vienna, Austria.

Please contact us to organize a meeting with E2DG team during the RESI Conference. To get more information on this conference follow this link.

 

March 29 – Apr 3, 2019.

AACR ANNUAL MEETING 2019, Atlanta, United States..

Please contact us to organize a meeting with E2DG team during the AACR 2019. To get more information on this conference follow this link.

 

April 30 – May 1, 2019.

BIOTRINITY 2019, London, UK.

Please contact us to organize a meeting with E2DG team during BioTrinity Conference. To get more information on this conference follow this link.  

Season's Greetings & Happy New Year!

From all of us at E2DG!

 

Nano2Clinic

The COST Action “Cancer nanomedicine – from the bench to the bedside” WEBSITE  now live at https://www.nano2clinic.eu 

BIO-EUROPE 2018 Meeting

5-7 November, 2018. 24th ANNUAL INTERNATIONAL PARTNERING CONFERENCE BIO-EUROPE, Copenhagen, Denmark

To get more information on this conference follow this link.

30th EORTC-NCI-AACR Meeting

13-16 November, 2018. 30th EORTC-NCI-AACR Symposium. Dublin, Ireland

To get more information on this conference follow this link.

Galien Medstart UP Meeting

24-25 October 2018. Galien Medstart’UP Meeting, New York, USA

E2DG selected to be part of the French delegation during the Galien Medstartup 2018 meeting, an initiative between The Galien Foundation and Business France to encourage and reward international partnerships between French and North American innovators in the Life Sciences Industry.

To get more information on this meeting follow this link.

COST Action

1st October 2018. COST Action Cancer nanomedicine – from the bench to the bedside”

We are pleased to announced that E2DG is part of the Management Committee of the COST Action CA17140 “Cancer nanomedicine – from the bench to the bedside”. To get more information on this action follow this link.

COST is a unique means to European investigators to foster their ideas and initiatives openly, freely, and through collaborative efforts. COST promotes the integration and development of a myriad of scientific communities, maximizing the national investment in RDI, and contributing decisively to the knowledge in Europe.

AACR Annual Meeting

14-18 April 2018. E2DG at AACR Annual Meeting 2018, Chicago, United States.

During the AACR meeting (14-18 April 2018) in Chicago, E2DG team will present a scientific poster showing our latest results on a novel BET inhibitor, NHWD-870. The poster can be visited on Sunday Apr 15, 2018 1:00-5:00 PM, McCormick Place South, Exhibit Hall A, Poster Section 37. We are looking forward meeting you in Chicago!

To get more information on this conference. follow this link.

BioFit 2017

 27-28 November 2017. E2DG at BioFit 2017, Strasbourg, France.

To get more information on this conference. follow this link.

Innovations en Oncologie

 22 November 2017. E2DG at Innovations en Oncologie, IDF Innov, Paris, France.

To get more information on this conference. follow this link.

53rd International Conference on Medicinal Chemistry

5 – 7 July 2017. E2DG at 53rd International Conference on Medicinal Chemistry (RICT 2017), Drug Discovery & Selection, Toulouse, France.

To get more information on this conference. follow this link.

First Boston-Paris Biotechnology Summit

18 May 2017. E2DG at First Boston-Paris Biotechnology Summit, Paris, France.

To get more information on this event. follow this link.

MEET2WIN 2017, Oncology Business Convention

11 – 12 May 2017. E2DG at MEET2WIN 2017, Oncology Business Convention, Bordeaux, France.

To get more information on this event. follow this link.

AACR Annual Meeting 2017

1 – 5 April 2017. E2DG at AACR Annual Meeting 2017, Washington, United State.

To get more information on this conference. follow this link.

15th International Congress on Targeted Anticancer Therapies

6 – 8 March 2017. E2DG at TAT 2017, 15th International Congress on Targeted Anticancer Therapies, Paris, France.

To get more information on this conference. follow this link.

BioFIT 2016

30 November – 1 December 2016. E2DG at BioFIT 2016, Lille, France.

To get more information on the BioFIT 2016 meeting, follow this link.

BIOTECH FINANCES

N° 744 (14 novembre 2016) N° 743 (31 octobre 2016)

In these two articles published in Biotech Finances, our preclinical experts highlight several obstacles that they must face in order to succeed in the transfer Life Science knowledge into new treatments in oncology. Additionally, they provide solutions that can help to overcome these obstacles in early drug development.

Read puplications

20th HUMAN ANTIBODIES & HYBRIDOMAS

9 – 11 November 2016. E2DG at 20th HUMAN ANTIBODIES & HYBRIDOMAS, Belfast, Northern Ireland.

To get more information on the 20th HUMAN ANTIBODIES & HYBRIDOMAS conference, follow this link.

SATT National Meeting 2016

21 October 2016. SATT National Meeting 2016, Paris, France

Universités AFSSI 2016

13 October 2016. Universités AFSSI 2016, Dijon, France.

To get more information on this meeting follow this link.

ESMO 2016 Congress

7- 11 October 2016. E2DG at ESMO 2016 Congress, Copenhagen, Denmark.

E-JASA 2016: Last Trends in Immunotherapy

1 October 2016. E-JASA 2016: Last Trends in Immunotherapy, Paris, France.

To get more information on the E-JASA meeting, follow this link.

Bio-Europe Spring 2016

4 April – 6 April 2016. E2DG at Bio-Europe Spring 2016, Stockholm, Sweden.